The Real Cost of Arthrosamid Injections in the UK

If you are considering Arthrosamid injections, it helps to know that the cost can vary quite a bit depending on the clinic and where you live. Prices usually cover an initial consultation, any necessary scans like ultrasounds or MRIs, the injection itself, and follow-up care. Differences in fees may reflect the level of expertise at the centre, the complexity of your case, and regional factors. Clinics such as MSK Doctors pride themselves on clear, upfront pricing, helping patients understand exactly what to expect. Consultant orthopaedic surgeon Professor Paul Lee, recognised for his evidence-based approach and role with the Royal College of Surgeons of Edinburgh, is involved in providing expert care and financial guidance at such clinics.

How Does Arthrosamid Stack Up Against Other Treatments?

Many begin managing knee OA with physiotherapy or over-the-counter pain relief, both affordable and widely accessible. Hyaluronic acid injections are another option, though they often require repeat treatments as their benefits tend to be shorter lived. Surgery, such as knee replacement, is a more costly and invasive step reserved for severe cases. Arthrosamid injections set themselves apart through a gel made from a biocompatible polymer that cushions the joint and may provide relief lasting several years. A 2022 review of research observed “statistically significant data... at both 52 weeks and 13 months, indicating the efficacy... at one year post injection” (Cole et al., 2022). A 2025 study further found that “Arthrosamid offers comparable short-term efficacy and modest advantage at 6 months. However, long-term superiority is limited” (Aykaç et al., 2025). While the upfront cost is higher, the potential for longer-lasting relief may lower overall treatment expenses. Centres like MSK Doctors combine these injections with physiotherapy and lifestyle advice for a well-rounded approach to managing symptoms.

What Do Patients and Research Tell Us?

Clinical studies suggest that Arthrosamid injections can reduce pain and improve knee function for many people with osteoarthritis. Cole et al. (2022) reported that “Arthrosamid seems to be an efficacious and safe treatment option... providing positive results for at least 2 years.” Patient reviews tend to echo this, with many noting improved mobility and longer symptom-free periods. Another recent study highlighted that “Arthrosamid showed the highest patient acceptable symptom state rates (72%, 54%, and 42% at 3, 6, and 12 months)” (Aykaç et al., 2025). Safety is equally important; reassuringly, preclinical research demonstrated that “2.5% Arthrosamid shows no apparent neurotoxic or cytotoxic effects in nerve cells” (Walmod et al., 2025). Professor Paul Lee emphasises honest, shared decision-making, helping patients set realistic goals and understand their treatment choices—an approach that builds trust and improves satisfaction.

Considering the Cost: How to Make an Informed Choice

Many private clinics in the UK offer flexible payment options for Arthrosamid injections, such as staged payments or all-inclusive packages covering follow-up care. Insurance coverage varies, so it pays to check the details beforehand. When exploring this treatment, ask about the full cost, what to expect during the procedure, and aftercare arrangements. Choosing a reputable centre like MSK Doctors, led by experts such as Professor Paul Lee, can provide peace of mind both medically and financially. Ultimately, weighing the initial investment against the chances of lasting pain relief and improved quality of life is key to a confident, informed decision.

In summary, Arthrosamid injections represent an important advancement in the treatment of knee osteoarthritis. Although they come with a higher initial cost, their potential to offer long-lasting relief makes them a compelling option for many. With transparent pricing, expert advice from leading clinicians, and comprehensive support, people living with knee OA in the UK can make choices that suit their health needs and budgets.

References

• Cole, A., Maulana, R., Whitehead, J., & Lee, P. (2022). A systematic review of the novel compound Arthrosamid Polyacrylamide (PAAG) hydrogel for treatment of knee osteoarthritis. Medical Research Archives, 10(8). https://doi.org/10.18103/mra.v10i8.2950
• Aykaç, B., Dinç, M., Nar, Ö. O., Karasu, R., & Bayrak, H. Ç. (2025). Comparative efficacy of polyacrylamide hydrogel versus hyaluronic acid and corticosteroids in knee osteoarthritis: A retrospective cohort study. Medicine, 104(15). https://doi.org/10.1097/MD.0000000000044655
• Walmod, P. S., Kusk, P., Jøhnk, N., Ankorina‐Stark, I., & Essex, A. (2025). An injectable 2.5% cross-linked polyacrylamide hydrogel (2.5 iPAAG) demonstrates no neurotoxicity in human induced pluripotent stem cells-derived iCell® GlutaNeurons. Frontiers in Toxicology. https://doi.org/10.3389/ftox.2025.1585430